Christopher Gibson - Director at RECURSION PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
RXRX on Nasdaq
All Insider Reports
All Insider Reports

Christopher Gibson - trading volume in the past year for RECURSION PHARMACEUTICALS, INC.

Holdings reported by Christopher Gibson for RECURSION PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 906,556 $3,136,683 $3.46 19 Feb 2026 Direct
Class B Common Stock 4,543,334 19 Feb 2026 Direct Class A Common Stock 5,896,700
Class B Common Stock 388,000 17 Feb 2026 by LAHWRAN-4 LLC Class A Common Stock 0
Class B Common Stock 386,000 17 Feb 2026 by LAHWRAN-3 LLC Class A Common Stock 0
Stock Option (Right to Buy) 282,500 17 Feb 2026 Direct Class A Common Stock 0
Class B Common Stock 50,000 17 Feb 2026 by Gibson Family Trust Class A Common Stock 0

Transactions reported by Christopher Gibson for RECURSION PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.